financetom
Business
financetom
/
Business
/
Colombia has best coffee harvest in decades, warns of lower 2025/26 crop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Colombia has best coffee harvest in decades, warns of lower 2025/26 crop
Oct 7, 2025 9:23 AM

BOGOTA (Reuters) -Colombia closed its best coffee year in more than three decades, boosted by favorable weather conditions and the impact of crop renewal, although production is expected to decline in the upcoming cycle, the National Federation of Coffee Growers said on Tuesday.

Coffee production in the world's third-largest producer after Brazil and Vietnam, rose 17% year-on-year to 14.87 million 60-kg bags between October 2024 and September 2025, exceeding the country's estimated annual output of 14 million bags.

"We are now beginning the 2025/2026 coffee cycle, which, due to the natural physiological response of the coffee tree and significant rainfall in the first half of the year, is projected to be a year of lower production," federation manager German Bahamon said on X.

Colombia has about 840,000 hectares under coffee cultivation, with approximately 540,000 families relying on the crop for their livelihoods.

Output of washed arabica coffee rose 7% year-on-year in September to 1.14 million bags, the Federation said, though that figure was down from the 1.24 million bags produced in August.

Coffee exports rose 6% in September to 1.06 million bags.

Colombia's statistics agency DANE reported on Monday that the value of coffee exports jumped 79.7% year-on-year between January and August to $3.67 billion, driven by high international coffee prices.

The following table shows Colombia's monthly coffee output and exports (in thousands of bags), starting with last month:

  Output Exports

2025

September 1,142 1,063

August 1,243 1,128

July 1,373 1,150

June 909 1,086

May 819 910

April 703 796

March 1,064 1,268

February 1,361 1,187

January 1,356 1,151

2024    

December 1,798 1,282

November 1,761 1,189

October 1,339 1,047

September 1,071 987

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Snowflake Stock Rises Ahead Of Q2 Earnings Report
Snowflake Stock Rises Ahead Of Q2 Earnings Report
Aug 27, 2025
Shares of Snowflake Inc ( SNOW ) are trading higher Wednesday as investors await the cloud data company’s second-quarter earnings report, scheduled for release after the market close. What To Know: The positive momentum could be part of a sympathy play after competitor MongoDB Inc posted strong quarterly results, beating analyst expectations on both the top and bottom lines. MongoDB’s...
Amylyx Halts Rare Brain Disorder Drug Program After Disappointing Trial
Amylyx Halts Rare Brain Disorder Drug Program After Disappointing Trial
Aug 27, 2025
Amylyx Pharmaceuticals, Inc. ( AMLX ) on Wednesday decided to discontinue the ORION program of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO, also known as ursodoxicoltaurine]) in adults living with progressive supranuclear palsy (PSP). PSP is a rare, degenerative brain disorder causing issues with balance, movement, eye movements, speech, swallowing, mood, and cognition. AMX0035 did not show differences compared to...
Delta to pay $78.75 million to resolve fuel dump lawsuit
Delta to pay $78.75 million to resolve fuel dump lawsuit
Aug 27, 2025
(Reuters) -Delta Air Lines agreed to pay $78.75 million to resolve a class action lawsuit over a 2020 fuel dump that doused tens of thousands of properties, including homes and schools, in Los Angeles and Orange counties in California. A proposed preliminary settlement was filed this week in Los Angeles federal court, and requires a judge's approval. The case stemmed...
Amylyx Halts Rare Brain Disorder Drug Program After Disappointing Trial
Amylyx Halts Rare Brain Disorder Drug Program After Disappointing Trial
Aug 27, 2025
Amylyx Pharmaceuticals, Inc. ( AMLX ) on Wednesday decided to discontinue the ORION program of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO, also known as ursodoxicoltaurine]) in adults living with progressive supranuclear palsy (PSP). PSP is a rare, degenerative brain disorder causing issues with balance, movement, eye movements, speech, swallowing, mood, and cognition. AMX0035 did not show differences compared to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved